Influence of gestational diabetes mellitus on the stereoselective kinetic disposition and metabolism of labetalol in hypertensive patients

European Journal of Clinical Pharmacology

Volumn 67, Issue 1, 2011, Pages 55-61

  Carvalho, Teresa Maria J P ^a   De Carvalho Cavalli, Ricardo ^a   Cunha, Sérgio P ^a   De Baraldi, Cláudia O ^a   Marques, Maria P ^a   Antunes, Natalícia J ^a   Godoy, Ana Leonor P C ^a   Lanchote, Vera Lucia ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Gestational diabetes mellitus; Hypertension; Labetalol; Pharmacokinetics; Pregnancy; Stereoisomers

Indexed keywords

LABETALOL;

ADOLESCENT; ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CONTROLLED CLINICAL TRIAL; DISTRIBUTION VOLUME; DOSAGE SCHEDULE COMPARISON; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DOSE COMPARISON; DRUG ELIMINATION; DRUG GLUCURONIDATION; DRUG HALF LIFE; DRUG METABOLISM; ENANTIOMER; FEMALE; HUMAN; HYPERTENSION; MAXIMUM PLASMA CONCENTRATION; PLASMA CONCENTRATION-TIME CURVE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; STEREOISOMERISM; THIRD TRIMESTER PREGNANCY; TIME TO MAXIMUM PLASMA CONCENTRATION;

ADMINISTRATION, ORAL; ADRENERGIC BETA-ANTAGONISTS; ADULT; AREA UNDER CURVE; BLOOD PRESSURE; DIABETES, GESTATIONAL; FEMALE; GLUCURONIDES; HUMANS; HYPERTENSION, PREGNANCY-INDUCED; INJECTIONS, INTRAVENOUS; LABETALOL; PREGNANCY; STEREOISOMERISM; YOUNG ADULT;

EID: 79151478921     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00228-010-0896-0     Document Type: Article

References (26)

1. CL Bryson GN Ioannou SJ Rulyak C Critchlow 2003 Association between gestational diabetes and pregnancy-induced hypertension Am J Epidemiol 158 1148 1153 10.1093/aje/kwg273 14652299
2. LA Magee 2001 Treating hypertension in women of child-bearing age and during pregnancy Drug Saf 24 457 474 1:CAS:528:DC%2BD3MXjvFygtrc%3D 10.2165/00002018-200124060-00004 11368252
3. RL Lalonde TL O'Rear JW Wainer KD Drda VL Herring MB Bottorff 1990 Labetalol pharmacokinetics and pharmacodynamics: evidence of stereoselective disposition Clin Pharmacol Ther 48 509 519 1:CAS:528:DyaK3MXhtFCmt7o%3D 10.1038/clpt.1990.187 2225711
4. H Jeong S Choi JW Song H Chen JH Fischer 2008 Regulation of UDP-glucuronosyltransferase (UGT)1A1 by progesterone and its impact on labetalol elimination Xenobiotica 38 62 75 1:CAS:528:DC%2BD2sXhsVOrtrbF 10.1080/00498250701744633 18098064
5. DW Boulton JM Dakers JP Fawcett TM Fiddes 1999 Transplacental distribution of labetalol stereoisomers at delivery Br J Clin Pharmacol 47 573 574 1:STN:280:DyaK1MzitVOrsA%3D%3D 10400466
6. PC Rubin L Butters AW Kelman C Fitzsimons J Reid 1983 Labetalol disposition and concentration-effect relationships during pregnancy Br J Clin Pharmacol 15 465 470 1:STN:280:DyaL3s3gsVGkug%3D%3D 6849783
7. RC Rogers BM Sibai WD Whybrew 1990 Labetalol pharmacokinetics in pregnancy-induced hypertension Am J Obstet Gynecol 162 362 366 1:STN:280:DyaK3c7nvValsg%3D%3D 2309815
8. T Saotome S Minoura K Terashi T Sato H Echizen T Ishizaki 1993 Labetalol in hypertension during the third trimester of pregnancy: its antihypertensive effect and pharmacokinetic-dynamic analysis J Clin Pharmacol 33 979 988 1:STN:280:DyaK2c%2FktlyrtA%3D%3D 8227470
9. RA Preston M Epstein 1999 Effects of diabetes on cardiovascular drug metabolism Diab Care 22 982 988 1:STN:280:DyaK1MzgtVynsg%3D%3D 10.2337/diacare.22.6.982
10. E Del Villar P Vega C Gaule E Sanchez 1990 Diabetes in female rats; changes in liver microsomal aminopyrine N-demethylase and UDP-glucuronyl transferase activities Eur J Drug Metab Pharmacokinet 15 279 285 10.1007/BF03190216 2128478
11. DY Lee MG Lee HS Shin I Lee 2007 Changes in omeprazole pharmacokinetics in rats with diabetes induced by alloxan or streptozotocin: faster clearance of omeprazole due to induction of hepatic CYP1A2 and 3A1 J Pharm Pharmaceut Sci 10 420 433 1:CAS:528:DC%2BD1MXht1ClsLvF
12. RK Sindhu JR Koo KK Sindhu A Ehdaie F Farmand CK Roberts 2006 Differential regulation of hepatic cytochrome P450 monooxygenases in streptozotocin-induced diabetic rats Free Radic Res 40 921 928 1:CAS:528:DC%2BD28XhtVCjtLzM 10.1080/10715760600801272 17015271
13. A Toda R Eyanagi H Saito S Soeda H Shimeno M Moriyama H Shigematsu 2005 Effects of experimental diabetes on hepatic drug metabolism in rats: the activities of flavin-containing monooxygenase, the phase II conjugation reactions and glutathione related enzymes Res Commun Mol Pathol Pharmacol 117 13 27 18426076
14. L Braun MJ Coffey F Pukás T Kardon G Nagy AA Conley B Burchell J Mandl 1998 Molecular basis of bilirubin UDP-glucuronosyltransferase induction in spontaneously diabetic rats, acetone-treated rats and starved rats Biochem J 336 587 592 1:CAS:528:DyaK1MXjvVCisQ%3D%3D 9841869
15. JA Johnson WS Akers VL Herring MS Wolfe JM Sullivan 2000 Gender differences in labetalol kinetics: importance of determining stereoisomer kinetics for racemic drugs Pharmacotherapy 20 622 628 1:CAS:528: DC%2BD3cXksF2qsrk%3D 10.1592/phco.20.7.622.35180 10853616
16. MP Marques EB Coelho NAG Dos Santos TJM Geleilete VL Lanchote 2002 Dynamic and kinetic disposition of nisoldipine enantiomers in hypertensive patients presenting with type-2 diabetes mellitus Eur J Pharmacol 58 607 614 1:CAS:528:DC%2BD38XpsFSgtrY%3D 10.1007/s00228-002-0528-4
17. Working Group Report on High Blood Pressure in Pregnancy 2000 National High Blood Pressure Education Program (NHBPEP) Am J Obstet Gynecol 183 S1 S22 10.1067/mob.2000.107928
18. World Health Organization (WHO) (1999) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
19. TMJP Carvalho RC Cavalli MP Marques SP Cunha CO Baraldi VL Lanchote 2009 Stereoselective Analysis of Labetalol in Human Plasma by LC-MS/MS: Application to Pharmacokinetics Chirality 21 738 744 1:CAS:528:DC%2BD1MXotFChs7g%3D 10.1002/chir.20673 19006203
20. O Papini C Bertucci SP Cunha NAG Santos VL Lanchote 2006 Quantitative assay of lorazepam and its metabolite glucuronide by reverse-phase liquid chromatography-tandem mass spectrometry in human plasma and urine samples J Pharm Biomed 40 389 396 1:CAS:528:DC%2BD28XovVSltA%3D%3D 10.1016/j.jpba.2005.07. 033
21. V Andrisano R Ballardini P Hrelia N Cameli A Tosti R Gotti V Cavrini 2001 Studies on the photostability and in vitro phototoxicity of labetalol Eur J Pharm Sci 12 495 504 1:CAS:528:DC%2BD3MXhsFSgs7w%3D 10.1016/S0928-0987(00)00218- 9 11231117
22. G Cheymol JM Poierier PA Carrupt B Testa J Weissenburger JC Levron E Snoeck 1997 Pharmacokinetics of β-adrenoceptor blockers in obese and normal volunteers Br J Clin Pharmacol 43 563 570 1:CAS:528:DyaK2sXks1Sjsr8%3D 10.1046/j.1365-2125.1997.00609.x 9205815
23. P Vega C Gaule E Sanchez E Del Villar 1986 Inhibition and activation of UDP-glucuronyltransferase in alloxanic-diabetic rats Gen Pharmacol 17 641 645 1:CAS:528:DyaL2sXmsFartw%3D%3D 3102313
24. MH Morrison GM Hawksworth 1984 Glucuronic acid conjugation by hepatic microsomal fractions isolated from streptozotocin-induced diabetic rats Biochem Pharmacol 33 3833 3838 1:CAS:528:DyaL2MXktlyhtA%3D%3D 10.1016/0006-2952(84) 90048-0 6439213
25. MH Grant SJ Duthie 1987 Conjugation reactions in hepatocytes isolated from streptozotocin-induced diabetic rats Biochem Pharmacol 36 3647 3655 1:CAS:528:DyaL1cXntlSquw%3D%3D 10.1016/0006-2952(87)90015-3 3675622
26. PI Eacho D Sweeny M Weiner 1981 Conjugation of ρ-nitroanisole and ρ-nitrophenol in hepatocytes isolated from streptozotocin diabetic rats J Pharmacol Exp Ther 218 34 40 1:CAS:528:DyaL3MXktlGls78%3D 6787190